453 total citations 37 papers, 351 citations indexed
About
Falk Re is a scholar working on Oncology, Surgery and Immunology.
According to data from OpenAlex, Falk Re has authored 37 papers receiving a total of 351 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 10 papers in Surgery and 9 papers in Immunology. Recurrent topics in Falk Re's work include Liver physiology and pathology (6 papers), Cancer Immunotherapy and Biomarkers (6 papers) and Cancer Research and Treatments (5 papers). Falk Re is often cited by papers focused on Liver physiology and pathology (6 papers), Cancer Immunotherapy and Biomarkers (6 papers) and Cancer Research and Treatments (5 papers). Falk Re collaborates with scholars based in Canada, United States and Italy. Falk Re's co-authors include L Makowka, B Langer, Blendis Lm, Phillips Mj, U Ambus, Bruce Taylor, Stefano Landi, B Langer, Göran Möller and L Collste and has published in prestigious journals such as Journal of Clinical Oncology, HemaSphere and PubMed.
In The Last Decade
Falk Re
34 papers
receiving
325 citations
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late)
cites ·
hero ref
This map shows the geographic impact of Falk Re's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Falk Re with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Falk Re more than expected).
This network shows the impact of papers produced by Falk Re. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Falk Re. The network helps show where Falk Re may publish in the future.
Co-authorship network of co-authors of Falk Re
This figure shows the co-authorship network connecting the top 25 collaborators of Falk Re.
A scholar is included among the top collaborators of Falk Re based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with Falk Re. Falk Re is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
All Works
20 of 20 papers shown
1.
Makowka, L, et al.. (1987). Allogeneic intrasplenic hepatocyte transplantation in the Gunn rat using cyclosporine A immunosuppression.. PubMed. 19(1 Pt 2). 1002–3.8 indexed citations
2.
Re, Falk, et al.. (1986). Excision of abdominal wall tumours and reconstruction with Marlex mesh.. PubMed. 29(3). 191–3.8 indexed citations
3.
Re, Falk, et al.. (1985). Pelvic exenteration for advanced primary and recurrent adenocarcinoma.. PubMed. 28(6). 539–41.17 indexed citations
4.
Makowka, L, et al.. (1983). Comparison of in-vivo thermochemotherapy of isolated rat liver through portal vein and hepatic artery.. PubMed. 26(3). 224–8.3 indexed citations
5.
Miles, John W., et al.. (1983). Genetic linkage studies with cleft lip and palate: report of two family studies.. PubMed. 3(3). 207–12.2 indexed citations
6.
Miyazaki, Masayuki, et al.. (1983). Reversal of lethal, chemotherapeutically induced acute hepatic necrosis in rats by regenerating liver cytosol.. PubMed. 94(2). 142–50.21 indexed citations
7.
Re, Falk, et al.. (1982). Prenatal diagnosis of a 5/15 translocation with 5p and proximal 5q trisomy. Cytogenetic and phenotypic findings.. PubMed. 18(3 Pt A). 143–51.4 indexed citations
8.
Makowka, L, et al.. (1981). Allogeneic and xenogeneic hepatocyte transplantation.. PubMed. 13(1 Pt 2). 855–9.10 indexed citations
9.
Makowka, L, et al.. (1981). Studies into the mechanism of reversal of experimental acute hepatic failure by hepatocyte transplantation. 1.. PubMed. 24(1). 39–44.41 indexed citations
10.
Re, Falk, et al.. (1980). Comparison of the antitumor effects of a synthetic biopolymer and standard adjuvants.. PubMed. 88(1). 126–36.6 indexed citations
11.
Letarte, Michelle, et al.. (1979). Serologic cross-reaction of murine and human Ia antigens.. PubMed. 11(4). 1745–7.5 indexed citations
12.
Ambus, U, et al.. (1978). Randomized trial of chemoimmunotherapy for resectable and non-resectable gastrointestinal cancer.. PubMed. 38. 541–5.2 indexed citations
13.
Re, Falk, et al.. (1977). Increased resistance to established tumor metastases after elimination of thymus - T-cell mediated suppression.. PubMed. 28. 161–3.1 indexed citations
14.
Re, Falk, et al.. (1977). B-lymphocyte alloantigens extracted from CLL cells.. PubMed. 9(1 Suppl 1). 161–4.1 indexed citations
15.
Re, Falk, et al.. (1976). Immunostimulation with intraperitoneally administered bacille Calmette Guérin for advanced malignant tumors of the gastrointestinal tract.. PubMed. 142(3). 363–8.19 indexed citations
16.
Re, Falk, et al.. (1976). Immunotherapy of malignant disease (Part 2).. PubMed. 21(1). 43–9.2 indexed citations
17.
Re, Falk, et al.. (1975). Oral bacille Calmette Guérin immunostimulation in malignant melanoma.. PubMed. 141(5). 747–54.6 indexed citations
18.
Re, Falk, et al.. (1973). The role of the mixed lymphocyte culture reaction in the stimulation of antibody production by human lymphocytes in vitro.. PubMed. 5(1). 349–52.1 indexed citations
19.
Re, Falk, et al.. (1973). Partial trisomy of chromosome 11: a case report.. PubMed. 77(4). 383–8.12 indexed citations
20.
Re, Falk, L Collste, & Göran Möller. (1969). In vitro correlates of transplantation immunity: the release of substances by immune lymphocytes confronted with specific antigens.. PubMed. 66(1). 51–7.15 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.